Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals.verified

603087.SS

Price:

$67.88

Market Cap:

$40.41B

Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and commercialization insulin analogues primarily in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro; Raplin, an insulin aspart injection; Raplin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection, as well as medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.

Industry

Medical - Instruments & Supplies

IPO Date

2020-06-29

Stock Exchange

SHH

Ticker

603087.SS

The PE Ratio as of December 2025 (TTM) for Gan & Lee Pharmaceuticals. (603087.SS) is 43.24

According to Gan & Lee Pharmaceuticals.’s latest financial reports and current stock price. The company's current PE Ratio is 43.24. This represents a change of 7.11% compared to the average of 40.37 of the last 4 quarters.

Gan & Lee Pharmaceuticals. (603087.SS) Historical PE Ratio (quarterly & annually)

How has 603087.SS PE Ratio performed in the past?

The mean historical PE Ratio of Gan & Lee Pharmaceuticals. over the last ten years is 38.94. The current 43.24 PE Ratio has changed 11.00% with respect to the historical average. Over the past ten years (40 quarters), 603087.SS's PE Ratio was at its highest in in the March 2023 quarter at 107.38. The PE Ratio was at its lowest in in the December 2022 quarter at -177.89.

Quarterly (TTM)
Annual

Average

38.94

Median

38.80

Minimum

-41.63

Maximum

87.75

Gan & Lee Pharmaceuticals. (603087.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Gan & Lee Pharmaceuticals. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 92.55%

Maximum Annual PE Ratio = 87.75

Minimum Annual Increase = -310.81%

Minimum Annual PE Ratio = -41.63

Quarterly (TTM)
Annual
YearPE RatioChange
202442.40-51.68%
202387.75-310.81%
2022-41.63-253.10%
202127.19-54.93%
202060.3392.55%
201931.33-11.00%
201835.2115.44%
201730.50-28.76%
201642.81-41.78%
201573.53-31.45%

Gan & Lee Pharmaceuticals. (603087.SS) Average PE Ratio

How has 603087.SS PE Ratio performed in the past?

The current PE Ratio of Gan & Lee Pharmaceuticals. (603087.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

29.51

5-year avg

35.21

10-year avg

38.94

Gan & Lee Pharmaceuticals. (603087.SS) PE Ratio vs. Peers

How is 603087.SS’s PE Ratio compared to its peers?

Gan & Lee Pharmaceuticals.’s PE Ratio is greater than Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (21.80), less than APT Medical Inc. (46.71), greater than Imeik Technology Development Co.,Ltd. (29.99), greater than Changchun High-Tech Industries (Group) Inc. (40.20), greater than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (14.00), greater than Beijing Tiantan Biological Products Co., Ltd. (24.70), less than Hangzhou Tigermed Consulting Co., Ltd. (73.20), greater than Beijing Tongrentang Co., Ltd (32.84), greater than iRay Technology Company Limited (39.30), greater than Shanghai Junshi Biosciences Co., Ltd. (-38.24),

Build a custom stock screener for Gan & Lee Pharmaceuticals. (603087.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gan & Lee Pharmaceuticals. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gan & Lee Pharmaceuticals. (603087.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gan & Lee Pharmaceuticals. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Gan & Lee Pharmaceuticals.'s PE Ratio?

How is the PE Ratio calculated for Gan & Lee Pharmaceuticals. (603087.SS)?

What is the highest PE Ratio for Gan & Lee Pharmaceuticals. (603087.SS)?

What is the 3-year average PE Ratio for Gan & Lee Pharmaceuticals. (603087.SS)?

What is the 5-year average PE Ratio for Gan & Lee Pharmaceuticals. (603087.SS)?

How does the current PE Ratio for Gan & Lee Pharmaceuticals. (603087.SS) compare to its historical average?